Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Edgewise Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| EWTX | NEO | |
|---|---|---|
Market Cap | $3.94B | $2.14B |
Volume | 810,104 | 2,228,400 |
Sector | Health | Health |
52-Week High | $48.35 | $19.91 |
52-Week Low | $14.89 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $2.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
